Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 19, 2009

View Archived Issues

Ex vivo IL-10 gene therapy correlates with functional repair of lung transplants

CH-5137291evaluated in preclinical models of castration-resistant prostate cancer

E-3810 exhibits potent antiangiogenic activity in preclinical studies

Favorable safety and lipid profiles with anacetrapib therapy in hyperlipidemia

Pioglitazone slows atherosclerosis progression in type 2 diabetes patients

Vasopressin V1a and V1b receptor antagonists reported by sanofi-aventis

Schering-Plough claims A2A receptor antagonists for the treatment of PD

Novel histamine receptor modulators in early development at Medivation

5-HT, DA and NE reuptake inhibitors disclosed by GSK for the treatment of anxiety

Vertex is developing ABC transporter modulators for the treatment of cystic fibrosis

Advanced BioHealing initiates prospective clinical trial for venous leg ulcers

Alkermes initiates phase II trial of ALKS-33 for alcohol dependence

Anacor starts phase I trial of AN-3365 for Gram-negative infections

Albireo presents clinical data on A-3309 in chronic idiopathic constipation

Pluristem Therapeutics reports 3-month follow-up data for PLX-PAD

Vivus reports results from phase III avanafil study in erectile dysfunction

Genzyme reports results from phase II/III trial of GENZ-644470 in hyperphosphatemia

Asterand to acquire BioSeek

Biocompatibles acquires Astron Clinica's inventory and intellectual property assets

FDA issues complete response to Genentech and Biogen's applications for rituximab in CLL

FDA committee votes that data for Prevnar 13 vaccine support safety and effectiveness

Sangamo presents update on phase I safety study of SB-728-T for HIV/AIDS

Chugai files for additional indication for Epogin in Japan

deCODE genetics files for bankruptcy in the U.S.

ImmuPharma reports final results from phase IIb trial of Lupuzor in SLE

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for June 17, 2025.
Zusduri flurry ends; ‘set up’ at ODAC, Urogen prevails with FDA
BioWorld
During a conference call after the U.S. FDA approval of Zusduri (mitomycin), Urogen Pharma Ltd. CEO Liz Barrett offered candid observations about a...
23andme founder-led group outbids Regeneron for company
BioWorld
The 23andme Holding Co.’s saga came full circle with founder Anne Wojcicki regaining control of the bankrupt genetic testing company in a bidding battle against...
Elevidys’ second liver death hits Sarepta, sends DMD ripples
BioWorld
How the U.S. FDA might respond became a serious question for Wall Street as Sarepta Therapeutics Inc. made known a second death due to acute liver failure with...